You are here
ACP's Guide to Adult Immunization
Produced by faculty of ACP's Quality Improvement Programs and members of the ACP Adult Immunization Advisory Board, this guide will help you develop systematic processes for incorporating immunization in your day-to-day practice.
Our intention is that this Guide will be read by and shared among the entire office team. You may find that Sections 1 and 2 are more beneficial to administrators and office staff, while physicians, physician assistants, nurse practitioners, and nurses may want to concentrate on Sections 3 and 4. Attending physicians and their residents will find residency clinic-specific information in Section 2.
The Guide is divided into four sections:
Section 1: Practice Improvement
- Immunization and the Chronic Care Model
- PDSA and Rapid Cycles of Change
- Measuring Change in Your Practice
- Incorporating Run Charts Into Daily Practice
Section 2: Practical Advice
- Applying the Chronic Care Model and PDSA Cycle to Any Immunization Setting
- Practice Management Issues
- Running a Vaccine Clinic
- Immunization Resources
- ACIP Immunization Schedule
Section 3: Vaccines and Their Indications
- Weighing Vaccine Benefit vs. Risk
- Pneumococcal Polysaccharide (PPSV23)
- Tetanus Toxoid/Td/Tdap
- Herpes Zoster
- Hepatitis A
- Hepatitis B
ACP Guide to Adult Immunization, Section 3, Vaccines and Their Indications, HPV (page 58)
Under the Administration subheading, the administration route for HPV4 vaccine is incorrectly listed as subcutaneous. The correct route of route of administration for HPV4 is intramuscular.
Section 4: Special Populations
- Women who are Pregnant or Breastfeeding
- Immunocompromised Persons
- Patients with Anatomical or Functional Asplenia
- Childhood Catch-up
- Health Care Workers (HCWs)
Editorial direction and production were made possible by a cooperative agreement with the Centers for Disease Control and Prevention (1U66IP000393-01). Printing of the ACP Guide to Adult Immunization was made possible by educational grants from Sanofi Pasteur, Merck Vaccines, and Pfizer, Inc.